• Home
  • About Us
    • Meet Our Team
    • Vision, Mission and Core Values
    • Trusted Partners
    • Giving Back
    • In the News
    • Awards
    • Careers
  • For Patients
    • Study Opportunities
    • Clinical Trial Opportunities
    • Sign Up to Participate
    • Types of Research
    • Find Us in the Community
    • Frequently Asked Questions
    • Testimonials
    • How We Use Your Information
    • Newsletters
  • For Researchers
    • Patient/Caregiver Panels
    • Pricing
    • Proposal Requests
    • Frequently Asked Questions
    • Industry Conferences
    • Diseases
      • Hemophilia
      • Multiple Sclerosis
      • Breast Cancer
      • Diabetes
      • Multiple Myeloma
      • Epilepsy
      • Non-Small Cell Lung Cancer
      • HIV
  • Referral Program
  • Blog
    • Patient Blog
    • Business Blog
  • Sign In
  • Case Studies
    • The Long and Winding Road to Care
    • Health Literacy Initiative’s PSA
    • Patient Perspectives on Clinical Trial Participation
    • Patient Journeys and Insights for Oncology and Rare Diseases
    • Market Access: A Patient Perspective
    • The Impact of Rare Diseases on Patients and Caregivers
    • The Role of Patient Advocacy Groups
    • Zebras Do Exist: The Diagnostic Odyssey of Rare Disease Patients
    • Patient Insights on Telehealth: A Case Study
    • Hearing is Believing: Reducing Barriers to Amplify the Patient Voice

Rare Patient Voice

Helping Patients with Rare Diseases Voice Their Opinions

  • Home
  • About Us
    • Meet Our Team
    • Vision, Mission and Core Values
    • Trusted Partners
    • Giving Back
    • In the News
    • Awards
    • Careers
  • For Patients
    • Study Opportunities
    • Clinical Trial Opportunities
    • Sign Up to Participate
    • Types of Research
    • Find Us in the Community
    • Frequently Asked Questions
    • Testimonials
    • How We Use Your Information
    • Newsletters
  • For Researchers
    • Patient/Caregiver Panels
    • Pricing
    • Proposal Requests
    • Frequently Asked Questions
    • Industry Conferences
    • Diseases
      • Hemophilia
      • Multiple Sclerosis
      • Breast Cancer
      • Diabetes
      • Multiple Myeloma
      • Epilepsy
      • Non-Small Cell Lung Cancer
      • HIV
  • Referral Program
  • Blog
    • Patient Blog
    • Business Blog
  • Sign In
  • Case Studies
    • The Long and Winding Road to Care
    • Health Literacy Initiative’s PSA
    • Patient Perspectives on Clinical Trial Participation
    • Patient Journeys and Insights for Oncology and Rare Diseases
    • Market Access: A Patient Perspective
    • The Impact of Rare Diseases on Patients and Caregivers
    • The Role of Patient Advocacy Groups
    • Zebras Do Exist: The Diagnostic Odyssey of Rare Disease Patients
    • Patient Insights on Telehealth: A Case Study
    • Hearing is Believing: Reducing Barriers to Amplify the Patient Voice

Helping patients and caregivers share their voices

Patient Advocacy Groups Partnering with Pharma – Thumbs up or down?

June 22, 2017 Wes Michael

We are happy to share the results of a study we recently conducted across our patient/caregiver panels. We asked patients and caregivers their opinions about patient advocacy groups. One of the issues we focused on was bio-pharma companies and their partnerships with advocacy groups to work together for treatments.

In our survey of over 3,000 US patients and caregivers across nearly 200 diseases and conditions, we found that a majority (55%) are in favor of patient advocacy groups partnering with pharmaceutical or biotechnology companies to develop drugs for medical conditions. Less than 10% are opposed. However, over one-third are not sure.

Many respondents provided reasons for their positions. Some of those supporting partnerships stressed that partnerships can enable drug development to take patient perspectives into account, that it is the best way to obtain funding, that it can accelerate the development of treatments, and that anything that might help obtain a cure or improvement should be tried:

  • “Advocacy groups are more aware of the ups and downs of a patient and can give a better understanding as to what needs to be included in the development of the needed drugs.” Hepatitis C patient
  • “Any help in research, funding, and treating diseases are expensive and impossible without the help of pharmaceutical companies.” Pemphigus patient
  • “I am in favor of ANYTHING that will help!” Huntington’s caregiver
  • “It might speed up lifesaving treatment.” Turner’s Syndrome caregiver

Those opposed feared loss of independence for the advocacy group, a conflict of interest where profit motive takes priority over patient needs, and simply a feeling that drugs may not be the answer.

  • “Advocacy groups should be separate so they are able to provide a true voice for their members.” Hemophilia B patient
  • “Advocacy groups should remain impartial to treatment options.” Juvenile Diabetes caregiver
  • “Because the Big Pharma is out to make money…period!” Multiple Sclerosis patient
  • “I don’t believe drugs are always the answer.” Trisomy X patient

Those who were unsure saw the benefit of cooperation, but were also concerned about a conflict of interest:

  • “This can be positive, but it also may feel like the advocacy group is too involved with pharma to really work for what’s best for patients.” Common Variable Immune Deficiency patient
  • “They should be in contact, but they should not be heavily influenced. One is for the patient, the other is for profit.” Hemophilia A patient
  • “There is a very fine line between partnering with a pharma company and in turn becoming an advocate for the drug product – it’s a very tricky situation.” Crohn’s patient
  • “If it were to help the patients I’m for it but I would not want an advocacy group pushing a specific product.” Von Willebrand Disease patient

Our conclusion is, to gain greater support of their members, advocacy groups looking to partner with biopharmaceutical firms should make sure to communicate the benefits of the partnership to patients. They should also take steps to ensure and demonstrate that the advocacy group, while cooperating, will maintain its independence and will make patients’ needs its priority over promoting a specific treatment.

The survey also explored other areas of interest to patient advocacy groups and pharmaceutical and biotechnology companies, including:

  • Awareness of advocacy groups
  • Involvement of patients/caregivers in advocacy groups
  • Reasons for lack of involvement
  • Importance of advocacy group function, and how well these functions are performed
  • Perceived success of advocacy/biopharma partnerships

Please let us know if you’d like a copy of the results.

As always, for the most up-to-date list of our US patient panels and counts, see: https://rarepatientvoice.com/for-biopharma-and-market-researchers/. This week we were at the United Spinal Association’s Roll on Capitol Hill, so we’ve added to our spinal cord injury panel!

Filed Under: Business

Latest Blog Posts

  • Weekly Warrior: Meet Emily
  • Weekly Warrior: Meet Dani
  • Meet Our Team: Jennifer Harscheid, Project Manager
  • A Testimonial from Glenna Crooks, Strategic Health Policy International
  • Weekly Warrior: Meet Kaitlyn

Check Out Our YouTube Channel!

https://youtu.be/cfjkqh5Ykp0

Read Our Newsletter

Read our Newsletter
What’s New at Rare Patient Voice?

Rare Patient Voice

711 Hampton Lane
Towson, Maryland 21286
ContactUs@RarePatientVoice.com
(443) 986-1949


Visit our international site, rarepatientvoice.global


Careers


For Patients

  • Learn about us
  • Vision, Mission and Core Values
  • Sign up to participate
  • Find us in the community
  • Read our blog for patients
  • Privacy Policy

For Related Groups

  • What is the Rare Patient Voice referral program?
  • Are you a researcher?
  • Read our blog for businesses

   Instagram TikTok

     
     

Rare Patient Voice, LLC, Market Research, Towson, MD

Rare Patient Voice, LLC, Market Research, Towson, MD

©2023. Rare Patient Voice. All Rights
Reserved. Privacy Policy. Disclaimers. Sitemap

©2023 . All Rights Reserved.

Copyright © 2023 · Genesis Framework · WordPress · Log in

Search Our Website

We use cookies to ensure the best experience with Rare Patient Voice. By clicking “Accept”, you agree to our privacy policy.
Privacy Policy   |    Cookies    |    Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT